Integra LifeSciences (NASDAQ:IART - Get Free Report) had its price objective decreased by stock analysts at Truist Financial from $26.00 to $21.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has a "hold" rating on the life sciences company's stock. Truist…
Continue reading...